PROS1 and autoimmune disease: As such, the Luminex assay using the stable trimeric S protein gave a high overall specificity of 99.2% and no cross-reactive antibodies were detected in sera from people infected with prepandemic coronaviruses or from patients with autoimmune diseases that can produce polyreactive antibodies.